Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-1967 | |
Phytochemical name or plant extracts | 4, 4’-dihydroxy-3, 3’, 9-trimethoxy-9, 9’-epoxylignan | |
PMID | 28839377 | |
Literature evidence | SUMMARY: The chemical investigation of the stems of W. scytophylla resulted in the isolation of 12 compoundsThe 12 compounds including six lignans (7-12), in which compound 8 was a new natural productThe isolated compounds 1 and 7-12 were evaluated for their antitumor activitiesThe chemotaxonomic significance of all the isolations was summarized. | |
IUPAC name | 4-[[4-[(4-hydroxy-3-methoxyphenyl)methyl]-5-methoxyoxolan-3-yl]methyl]-2-methoxyphenol | |
Phytochemicals’ class or type of plant extracts | Lignan | |
Source of phytochemicals or plant Extracts | Wikstroemia scytophylla | |
Geographical availability | China South-Central, Tibet | |
Plant parts | Stem | |
Other cancers | Breast cancer, Lung cancer, Colon cancer | |
Target gene or protein | NA | |
Gene or Protein evidence | NA | |
Target pathways | NA | |
IC50 | >40 μM against MCF-7 | |
Potency | Compounds 1 and 7-12 exhibited weak antitumor activities (IC50>40 μM). Compound 11 is 4, 4’-dihydroxy-3, 3’, 9-trimethoxy-9, 9’-epoxylignan | |
Cell line/ mice model | HL-60, SMMC-7721, A549, MCF-7, and SW480 | |
Additional information | NA | |
PubChem ID | 75031600 | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:833183-1 | |
Safety | NA |